Seizure risk assessment for epilepsy
Predicting epileptic seizures are crucial. MJN Neuroserveis has developed SERAS, a non-invasive, discrete and wearable device to alert users of a pending epileptic attack. The device, which comprises an earpiece, reads the electroencephalogram and alerts the user via mobile application. What's more, the device monitors the user's brain activity, logging key medical information, including the number of seizures suffered, their intensity and frequency. SERAS can help patients significantly reduce, if not avert accidents from seizures, allowing science and doctors to go a step further in the research of neurological pathologies. The project is expected to boost commercialisation plans and scale-up business to the goal of EUR 27 million turnover by 2025.
Fields of science
Call for proposalSee other projects for this call